Docetaxel and cisplatin in head and neck cancer.
Schöffski
P
P
Wanders
J
J
Verweij
J
J
Fumoleau
P
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects*; D004232:Diuretics; D000077143:Docetaxel; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D007684:Kidney Tubules / Q000473:pathology; D008274:Magnesium / Q000627:therapeutic use*; D008275:Magnesium Deficiency / Q000139:chemically induced* / Q000188:drug therapy; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D043823:Taxoids
D004232:Diuretics; D043823:Taxoids; D000077143:Docetaxel; D008274:Magnesium; D017239:Paclitaxel; D002945:Cisplatin